These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 4081555)

  • 1. [Enteral resorption of ioxitalamate].
    Klingmüller V
    Rontgenblatter; 1985 Nov; 38(11):350-2. PubMed ID: 4081555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
    Lacour B; Lacroix C; Jungers P; Bailly M
    Ann Biol Clin (Paris); 1984; 42(6):407-11. PubMed ID: 6532266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of contrast media by the immature rabbit. Comparison of Renografin and Iopamidol.
    Rosenbaum DM; Caldicott WJ
    Invest Radiol; 1984; 19(2):123-8. PubMed ID: 6533102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative experimental study of central nervous system tolerability of the administration of iopamidol, metrizamide, ioxitalamate, ioxaglate and iocarmate].
    Cahn J; Borzeix MG; Cahn R
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):774-8. PubMed ID: 6670839
    [No Abstract]   [Full Text] [Related]  

  • 5. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time- and dose-dependent cytotoxicities of ioxitalamate and indigocarmine in human nucleus pulposus cells.
    Kim KH; Kim YS; Kuh SU; Park HS; Park JY; Chin DK; Kim KS; Cho YE
    Spine J; 2013 May; 13(5):564-71. PubMed ID: 23406968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral angiography with the contrast medium vasobrix 32 (ioxitalamate) (author's transl)].
    Samec P; Zeiler K; Reisner T; Klausberger EM
    Wien Klin Wochenschr; 1978 Jan; 90(2):70-3. PubMed ID: 622834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Contrast medium arachnitis' following lumbosacral myelography with water-soluble contrast media].
    Claass A; Piepgras U; Wussow W
    Rontgenpraxis; 1982 May; 35(5):174-85. PubMed ID: 7046088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enzyme determination in the urine for the evaluation of kidney tolerance of the water-soluble roentgen contrast medium iopamidol].
    Hartmann HG; Jutzler GA; Bambauer R; Keller HE; Maruhn D
    Radiologe; 1984 Sep; 24(9):442-5. PubMed ID: 6494455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiopaque contrast media. XLVI - Preliminary studies of the metabolism of iopamidol in the dog, the rabbit and man.
    Pitrè D; Tirone P; Viviani G
    Farmaco Sci; 1980 Oct; 35(10):826-35. PubMed ID: 7450018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enteral resorption and bioavailability of norfenefrine].
    Hengstmann JH; Goronzy J
    Arzneimittelforschung; 1980; 30(12):2164-7. PubMed ID: 7194079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sodium salts or methylglucamine salts in contrast media for infusion pyelography? (author's transl)].
    Taenzer V; Albrecht A; Clauss W; Held I
    Radiologe; 1981 Jun; 21(6):288-90. PubMed ID: 7022552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contrast medium resorption in ERCP].
    Carstensen F; Wurbs D
    Z Gastroenterol; 1993 Jun; 31(6):369-75. PubMed ID: 8212753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of radiographic contrast media on results of urinalysis, with emphasis on alteration in specific gravity.
    Feeney DA; Osborne CA; Jessen CR
    J Am Vet Med Assoc; 1980 Jun; 176(12):1378-81. PubMed ID: 7429935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of renal function before and after intravenous injection of non-cholangiographic water soluble contrast media in rats.
    Verbaeys A; Ringoir S; Kesteloot D; Van Maele G; Lameire N
    Acta Urol Belg; 1995 Mar; 63(1):103-8. PubMed ID: 7725984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA; Sheth RD; Gidal BE
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interference of several radiological contrast media in the determination of proteinuria].
    Myara I; Chamaki MS; Lagrange C; Lemonnier A
    Ann Biol Clin (Paris); 1985; 43(4):347-8. PubMed ID: 4091298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.